Are ILC2s Jekyll and Hyde in airway inflammation?

Area of Science:

• Immunology
• Pulmonology
• Cell Biology

Background:

• Asthma is a complex airway disease involving inflammation, hyperreactivity, mucus, and remodeling.
• Group 2 innate lymphoid cells (ILC2s) are key in initiating type 2 inflammation in allergic asthma.
• ILC2s respond to epithelial-derived cytokines (IL-33, IL-25, TSLP) and produce key type 2 cytokines (IL-5, IL-13, IL-9).

Purpose of the Study:

• To review the heterogeneity and plasticity of ILC2s in asthma.
• To explore regulatory mechanisms and diverse roles of ILC2s in allergic inflammation.
• To discuss ILC2 function in non-allergic asthma and airway suppression.

Main Methods:

• Literature review of accumulating evidence on ILC2s in asthma.
• Analysis of ILC2 functional plasticity in different asthma phenotypes.
• Examination of ILC2 interactions with other cells and their role in lung repair.

Main Results:

• ILC2s orchestrate cellular responses and interact with multiple cell types in asthma.
• ILC2s exhibit functional plasticity, differentiating into ILC1-like cells in non-allergic asthma.
• ILC2s contribute to both inflammation propagation and lung tissue repair.

Conclusions:

• ILC2s are central players in allergic asthma, driving type 2 immunity.
• ILC2 plasticity allows adaptation to diverse immune microenvironments in asthma.
• Understanding ILC2 regulation is crucial for developing asthma therapies.